Exelixis Access Services

Exelixis Access Services (EASE) includes programs designed to support patients who are prescribed Exelixis oncology drugs Cabometyx or Cometriq (Table).

EASE Programs

The EASE programs are drug-specific and provide financial, access, and reimbursement support for eligible patients.

Click here to enroll your patients who have been prescribed Cabometyx. Click here to enroll your patients who have been prescribed Cometriq.

Cabometyx 30-Day Free Trial Program

The 30-Day Free Trial Program provides a free trial to help new Cabometyx patients start treatment quickly, regardless of insurance type. A 30-day additional supply may be available to patients with a payer decision delay of ≥5 days.

• Limited to on-label indications
• Must be new prescription
• Restrictions and eligibility rules apply.

Cabometyx Dose Exchange Program

The Dose Exchange program provides a free 15-tablet supply of Cabometyx in the lower dose to help patients who require a dose reduction.

• Patients are required to return any unused product
• Additional restrictions and eligibility rules apply.

EASE Co-Pay Program

Eligible, commercially insured patients may pay as little as $0 per month for Cabometyx or Cometriq. Annual and transaction limits apply.

EASE Patient Assistance Program

Eligible patients who are uninsured or are insured but cannot afford the cost of the medication may receive Cabometyx or Cometriq free of charge.

TABLE Exelixis Oncology Drugs